5 ratings updates for Smith & Nephew stock

Spinal Tech

Smith & Nephew was reissued a "hold" rating from Berenberg Bank, according to a Sleek Money report.

Here are five other recent ratings for Smith & Nephew:

 

• JPMorgan & Chase Co.: Neutral rating
• BNP Paribas: Outperform rating
• AlphaValue: Buy rating
• Sanford C. Bernstein: Outperform rating
• Consensus rating is "Hold"

 

The average price target of GBX 1,135.63 is $16.99.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers